Dr. Detlef Schumann

Vorstandsmitglied, Chief Executive Officer (CEO), TETEC AG - Tissue Engineering Technologies AG

Reutlingen, Deutschland

Fähigkeiten und Kenntnisse

Pharmazie
Management
Mergers & Acquisitions
New Business Development
Strategieentwicklung
Pharmaceutical degree and german approbation
Excellent clinical
industrial and academic network in orthopedics
trauma and spine
Adapt easily to new concepts and responsibilities
Know-how in pharmaceutical production
Program Management
Quality control and regulatory affairs
Cartilage and bone tissue engineering and mechanob
Human stem cell biology
Forschung und Entwicklung
Anwendung
Stammzelle
Rapid Prototyping
Marketing
Business Development
Experience in setting up new large medical centers
Strong and proven understanding and experience in

Werdegang

Berufserfahrung von Detlef Schumann

  • Bis heute 3 Jahre und 2 Monate, seit Apr. 2021

    Managing Director

    CeGaT GmbH
  • Bis heute 3 Jahre und 9 Monate, seit Sep. 2020

    Chief Executive Officer (CEO)

    TETEC AG - Tissue Engineering Technologies AG

    Chairman of the Board CEO, CFO

  • 2 Jahre und 4 Monate, Mai 2018 - Aug. 2020

    Vice President Front End Innovation & Materials & Sterile Technology

    BBraun Aesculap

  • 5 Jahre und 1 Monat, Apr. 2013 - Apr. 2018

    New Business development manager Regenerative Materials Europe & Asia

    DSM Biomedical

  • 5 Jahre und 3 Monate, Feb. 2008 - Apr. 2013

    R&D and Program Manager Orthopaedics & Drug Delivery

    DSM Biomedical

    * R&D Management of internal and external research projects in orthopaedics/trauma & Drug Delivery - set up of worldwide collaborations with academical and clinical partners - design of in-vitro and in-vivo studies for biomedical applications - Discussions with clinicians to find biomaterial/device solutions for their clinical needs - Contact partner for academics and clinicians in governmental programs (e.g.BMM) - R&D contact for medical device industry in the orthopaedic and trauma field

  • 1 Jahr und 3 Monate, Okt. 2006 - Dez. 2007

    Postdoctoral scholar

    Massachusetts Institute of Technology and Harvard Medical School

    Alexander von Humboldt Scholar Postdoc at MIT and Harvard Department of biomedical engineering (MIT) Harvard Medical - Center for genetics (Harvard) Investigated the influence of mechanobiological load on OA explants in a simulated in vivo environment to investigate changes in catabolic or anabolic pathways on the gene and protein level. - Novel knowledge could help in innovative drug design for the treatment of degenerative diseases of the musculoskeletal system (e.g. Osteoarthritis)

  • 1 Jahr und 2 Monate, Aug. 2005 - Sep. 2006

    Postdoc

    National University of Singapore

    Postdoc Headed large animal trial for lumbar spine fusion. Bone Tissue engineering. Application of modern techniques in regenerative medicine (Rapid prototyping of spinal cages, innovative biomaterial design, growth factor delivery strategies, stem cell culture and application) Bioreactor design for osteochondral repair. Stem cell applications. Large animal operation and project management. Supervision of PhD and master students.

  • 1 Jahr und 4 Monate, Apr. 2004 - Juli 2005

    Postdoc and Center manager/coordinator

    Center for medical Biotechnologies

    R&D Management and Center Management Regenerative Therapies (R&D): Human Stem cell applications.Cartilage and Bone regeneration using innovative biomaterials (custom made) plus drug delivery strategies and human bone marrow derived stem cells. - Management of architectural, financial and inventory aspects - Responsible for business affairs - Did business plan writing for start up company - Organised transfer of six research units from different departments into the center - Public relation management

  • 4 Jahre und 11 Monate, Aug. 1999 - Juni 2004

    Research fellow

    University Hospital Regensburg

    Research for PhD thesis. Bioreactor (3x) design to apply mechanobiological load (direct compression, hydrostatic and ultrasound) on human bone marrow derived stem cells for cartilage regeneration strategies. Design of intravital microscopy techniques to investigate Angiogenisis in meniscal, chondrocytes or stem cell loaded biomaterials during their chondrogenic differentiation in vivo.- Instructed and supervised the lab personal and medical undergraduate/graduate students studying for a doctorate.

  • 6 Monate, Nov. 1999 - Apr. 2000

    Internship

    Bristol Meyers Squibb

    - Managed GMP and GLP affairs in the Quality Control - Manufactured cytostatics and other drugs under sterile conditions - Developed and validated new analytical methods - Did all kinds of modern analytical methods (HPLC, GC, IR, UV-VIS, TLC etc.) - Project Management

  • 7 Monate, Mai 1999 - Nov. 1999

    Internship

    Thurn und Taxis Pharmacy

    - Manufactured drugs - Supervised and performed drug control and storage - Advised customers - Managed economic affairs

Ausbildung von Detlef Schumann

  • 1 Jahr und 3 Monate, Okt. 2006 - Dez. 2007

    Osteoarthritis

    Mass. Institute of Technology/ Harvard Medical School

    - Influence of mechanobiological loading on healthy and pathological modified (Osteoarthritis) human cartilage tissue in a simulated in vivo situation.. - Novel knowledge could help in innovative drug design for the treatment of degenerative diseases of the musculoskeletal system.

  • 1 Jahr und 2 Monate, Aug. 2005 - Sep. 2006

    Applied orthopaedic research

    National University of Singapore, Orthopaedic surgery/Bioengineering/ NUSTEP

    - In vivo study of spinal fusion on large animals (pigs) using stem cells, growth factors and special designed biodegradable FDM made PCL-TCP biocages - Bone Tissue Engineering, Biomaterial design using electrospinning (Collagen (I and II), PCL and HYAFF nanofibers) and FDM techniques (PCL-TCP)

  • 3 Jahre und 8 Monate, Sep. 2000 - Apr. 2004

    Regenerative Medicine - Pharm. Technology

    University of Regensburg Germany / University Hospital Trauma Surgery

    - Instructed and supervised lab personal and medical undergraduate/graduate students studying for a doctorate - Tissue Engineering of cartilage with human mesenchymal stem cells (MSC) - Mechanobiological influences on human stem cell differentiation - Angiogenesis research - Patent defense

  • 4 Jahre und 3 Monate, Nov. 1994 - Jan. 1999

    Pharmacy

    University of Regensburg

    Relevant Coursework: e.g. • Pharmaceutical Chemistry • Pharmaceutical Technology • Pharmaceutical Biology • Pharmacology, Microbiology, Instrumental Analysis, Physics

Sprachen

  • Deutsch

    -

  • Englisch

    -

  • Spanisch

    -

  • Französisch

    -

Interessen

Medical devices
Drug Delivery
Bone and Cartilage Repair
Regenerative medicine
Stem cell and biomaterial research
Angiogenesis
Tango argentino
Baseball

21 Mio. XING Mitglieder, von A bis Z